Streetbeat News

Stock Prices

AVAXUSD

Avalanche (AVAX) has seen a price increase of 6.46% in the past 24 hours, reaching $28.84. Over the past week, the price has risen by over 12%, with trading volume climbing 49%. The current market cap is $11.36 billion, ranking it #14.

Portfolio Pulse from Benzinga Insights

July 16, 2024 | 7:01 pm

CLDX

Analysts have provided mixed ratings for Celldex Therapeutics (NASDAQ:CLDX) over the past three months, with a majority being bullish. The average 12-month price target remains at $77.4. Despite financial challenges, including a significant revenue decline and negative net margins, the company shows strong ROE and ROA.

Portfolio Pulse from Benzinga Insights

July 16, 2024 | 7:01 pm

INSP

Inspire Medical Systems (NYSE:INSP) has received mixed ratings from six analysts over the past three months, with a recent average price target of $220.33, down from $243.00. Analysts have adjusted their ratings and price targets in response to market conditions and company performance. Despite positive revenue growth, the company faces challenges in profitability and returns.

Portfolio Pulse from Benzinga Insights

July 16, 2024 | 7:00 pm

IONS

Ionis Pharmaceuticals (NASDAQ:IONS) has received a range of analyst ratings over the past three months, with a majority being bullish. The average 12-month price target has increased to $66.17. Analysts have adjusted their ratings and price targets based on recent developments, reflecting a positive outlook for the company despite some financial challenges.

Portfolio Pulse from Benzinga Insights

July 16, 2024 | 7:00 pm

HASI

Analysts have shared mixed evaluations of HA Sustainable (NYSE:HASI) over the past three months, with a majority being bullish. The average 12-month price target has increased to $42.6, reflecting a 6.5% rise from the previous target. Key analysts from firms like JP Morgan, Oppenheimer, TD Cowen, and B. Riley Securities have raised their price targets, indicating positive sentiment. HA Sustainable has shown strong financial performance with significant revenue growth, high net margins, and effective debt management.

Portfolio Pulse from Benzinga Insights

July 16, 2024 | 7:00 pm

SOLUSD

Solana's (SOL) price increased by 3.89% in the past 24 hours, continuing a positive trend with a 14.0% gain over the past week. Trading volume climbed 27.0%, and the circulating supply increased by 0.28%. SOL's market cap is now $74.97 billion, ranking it #5.

Portfolio Pulse from Benzinga Insights

July 16, 2024 | 7:00 pm

DJT

SPY

A Reuters/IPSOS poll reveals that 80% of registered U.S. voters believe the country is spiraling out of control following an assassination attempt on Donald Trump. Trump leads Joe Biden 43% to 41% among registered voters, within the poll's 3-point margin of error. Additionally, 65% of Republican voters view Trump's survival as divine intervention.

Portfolio Pulse from Benzinga Newsdesk

July 16, 2024 | 6:59 pm

GOOG

URAA

Rising energy demands from AI and data centers are increasing interest in uranium, despite recent price declines. The Direxion Daily Uranium Industry Bull 2X Shares (URAA) ETF, which offers leveraged exposure to uranium prices, has shown volatility since its launch. Alphabet Inc (GOOG) is also highlighted for its significant energy consumption in AI operations.

Portfolio Pulse from Joshenomoto@benzinga.com

July 16, 2024 | 6:52 pm

CYBN

DRUG

ENVB

MNMD

SEEL

A coalition of prominent researchers has urged the FDA to approve MDMA-based therapy for PTSD, highlighting its proven safety and efficacy. This comes as the FDA is set to rule on Lykos Therapeutics' MDMA therapy by August 11. The paper emphasizes the urgent need for effective PTSD treatments, citing high suicide rates among U.S. military veterans.

Portfolio Pulse from Benzinga Newsdesk

July 16, 2024 | 6:51 pm

HUMA

Humacyte, Inc. (NASDAQ:HUMA) stock is trending on Tuesday due to several positive developments, including new board members, a license agreement with Pluristyx, and receiving RMAT designation from the FDA. Analysts have also adjusted their price targets for the stock.

Portfolio Pulse from Dylan Berman

July 16, 2024 | 6:48 pm